Packaging machinery

Hanz Biotechnology (Suzhou) Co., Ltd. (hereinafter referred to as 'Hanz Bio') was established in March 2024 and is located in Suzhou Industrial Park. Hanzbio is selected as 2024 Technology Leading Talent Project and a 2025 Technology-based SME. We focuses on building a leading Lipid Nanoparticle (LNP) drug delivery platform, committed to addressing the challenges faced by LNP technology in the biopharmaceutical industry, such as high patent barriers, high synthesis difficulty, low delivery efficiency, high immunogenicity, and poor extrahepatic targeting.

The core team is composed of top nucleic acid drug delivery scientists and experienced senior executives in biopharmaceutical industrialization, including those from renowned domestic and international universities such as Tsinghua University, Peking University, Sichuan University, and the University of Pennsylvania, as well as MNC enterprises like Eli Lilly, Roche, and Bayer.